These AMCP, AMCP Learn, and Journal of Managed Care & Specialty Pharmacy resources will help advance the role of value-based contracts to improve access and affordability of medications.
In this guest blog post, Jennifer Graff, PharmD , discusses incorporating value in coverage decisions and how this applies to AMCP's efforts in addressing value and access.
During AMCP 2022 in March, Dr. Kali Cyrus lead a workshop titled: A Primer on Bias from Discovery to Implementing Strategies to Address. AMCP CEO, Susan Cantrell explores the highlights from this workshop and how managed care professionals may be able to implement Dr. Cyrus' strategies in their day-to-day.
In 2016, AMCP made pre-approval information exchange (PIE) a legislative priority recognizing its vital importance to patients. On June 8, 2022, the U.S. House of Representatives passed the PIE Act of 2022. Learn more about PIE as a legislative priority for AMCP.
During the COVID-19 crisis, managed care professionals are facing unique challenges to deliver patient care. This resource center is designed to aggregate timely information for AMCP members and stakeholders.
AMCP Format 4.1 includes new sections describing the evidence needs of HCDMs for unapproved products nearing the end of the product development pipeline, as well as unapproved uses of existing products for which FDA approval is being sought.
